Back to search

Article

Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer

2023-08-21

Abstract excerpt

Neuroendocrine prostate cancer (NEPC) is a highly aggressive subtype of prostate cancer (PC) that commonly emerges through a transdifferentiation process from prostate adenocarcinoma and evades conventional therapies. Extensive molecular research has revealed factors that drive lineage plasticity, uncovering novel therapeutic targets to be explored. A diverse array of targeting agents is currently under evaluation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7fb389f4-43d8-5959-b68b-3eac66de2a72
DOI
10.20944/preprints202308.1415.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting Key Players of Neuroendocrine Differentiation in Prostate CancerDOI 10.20944/preprints202308.1415.v1
Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer.Semantic proximity
Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate CancerSemantic proximity
The Many Faces of Neuroendocrine Differentiation in Prostate Cancer ProgressionSemantic proximity
Molecular model for neuroendocrine prostate cancer progressionSemantic proximity
Therapy considerations in neuroendocrine prostate cancer: what next?Semantic proximity
Role of MicroRNAs in Neuroendocrine Prostate CancerSemantic proximity
Cellular plasticity and the neuroendocrine phenotype in prostate cancer.Semantic proximity
[Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions].Semantic proximity
Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancerSemantic proximity
The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage PlasticitySemantic proximity
Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical OutcomesSemantic proximity
Neuroendocrine Differentiation in Prostate Cancer Requires ASCL1Semantic proximity
Select a neighboring publication to make it the new centre.